Stada gives Scarlett-Smith a permanent role

Stada gives Scarlett-Smith a permanent role
Roger Scarlett-Smith has been appointed president of Stada UK

23 April 2019 - Deborah Wilkes

Roger Scarlett-Smith is taking up a permanent position at Stada Arzneimittel following six months as interim managing director of the company's Thornton & Ross business in the UK.

Scarlett-Smith – who spent three decades at GlaxoSmithKline Consumer Healthcare – is now president of Stada UK with responsibility for a number of business areas including generics and OTC medicines.

When Scarlett-Smith joined Thornton & Ross in October 2018, the company said it would be for a "minimum period of six months" (click here to read the News story).

He retired from GlaxoSmithKline Consumer Healthcare in September 2016 after 32 years with the company.

At the time of his retirement, Scarlett-Smith was head of global categories. He had held a number of other senior positions at the Consumer Healthcare business, including president North America, president Europe, managing director for Australia and New Zealand, and general manager for the UK.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE

Click tags below for more information on topics:

Stada

Back to Industry News

Share this page: